Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study.
Saved in:
| Title: | Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study. |
|---|---|
| Authors: | Samson SL; Baylor College of Medicine, Houston, TX, USA. samson.susan@mayo.edu.; Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. samson.susan@mayo.edu., Gu F; Peking Union Medical College Hospital, Beijing, China., Feldt-Rasmussen U; Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen University, Copenhagen, Denmark., Zhang S; Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China., Yu Y; West China Hospital, Sichuan University, Chengdu, China., Witek P; Military Institute of Medicine and Medical University of Warsaw, Warsaw, Poland., Kalra P; MS Ramaiah Medical College and Hospitals, Bengaluru, India., Pedroncelli AM; Novartis Pharma AG, Basel, Switzerland.; Recordati AG, Basel, Switzerland., Pultar P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Jabbour N; Novartis Pharma AG, Basel, Switzerland., Paul M; Novartis Pharma AG, Basel, Switzerland., Bolanowski M; Wroclaw Medical University, Wroclaw, Poland. |
| Source: | Pituitary [Pituitary] 2021 Dec; Vol. 24 (6), pp. 887-903. Date of Electronic Publication: 2021 Jul 18. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9814578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7403 (Electronic) Linking ISSN: 1386341X NLM ISO Abbreviation: Pituitary Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
